2024 Volume 38 Issue 2 Pages 244-249
The chapter structure of Japanese Pediatric Guidelines for The Treatment and Management of Asthma (JPGL) 2023 underwent reorganization from JPGL 2020, resulting in two significant changes. Firstly, the discussion on the epidemiology and risk factors associated with asthma development, previously described throughout various chapters, is now consolidated into a single chapter. Secondly, the description of risk factors for acute exacerbations now occupies a separate chapter (Chapter 6).
Additionally, the main changes were as follows: 1) Updating the data from "Epidemiological surveys conducted by the Ministry of Health, Labour and Welfare and the Japanese Society of Pediatric Allergy and Clinical Immunology" to the latest version; 2) Substantial revisions to the "Table of prevalence in Japan" based on findings from recent large-scale surveys; and 3) Incorporation of "latest findings" based on more than 30 new articles, primarily from Japan, published after 2020. Despite limited evidence linking SARS-CoV-2 to development and acute exacerbation of childhood asthma. The epidemic pattern of each viral infection has undergone a significant change since the onset of the COVID-19 pandemic.
